Stockreport

With TScan Therapeutics Up 12%, Insider Buyers Count Their Returns [Yahoo! Finance]

TScan Therapeutics, Inc.  (TCRX) 
PDF The company's market value increased by US$27m as a result of the stock's 12% gain over the same period. Put another way, the original US$108.8k acquisition is now worth [Read more]